Efficacy of decitabine in the treatment
✍
P.W. Wijermans; B. Rüter; M.R. Baer; J.L. Slack; H.I. Saba; M. Lübbert
📂
Article
📅
2008
🏛
Elsevier Science
🌐
English
⚖ 96 KB
Chronic myelomonocytic leukemia (CMML) characterized by cytopenias, bone marrow and peripheral blood cell dysplasia is notoriously hard to treat. Recent reclassification of CMML as a myelodysplastic/myeloproliferative (MDS/MPS) disease rather than a myelodysplastic syndrome (MDS) by the World Health